Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Johns Hopkins Launches New COVID-19 Testing Insights Initiative

By HospiMedica International staff writers
Posted on 09 May 2020
Johns Hopkins University (Baltimore, MD, USA) has launched the COVID-19 Testing Insights Initiative, a one-stop resource hub that fills the void of publicly-available information about COVID-19 testing data and offers critical insights, resources, and expert analysis about COVID-19 testing in the US.

In the coming weeks and months, viral tests for the presence of COVID-19 infection as well as serological tests for antibodies and possible immunity will be critical to measure the spread of the disease. More...
Governments, businesses, and families will rely on data from these tests as well as answers to questions about testing capacity as they make decisions about the path forward. However, local testing data are not currently publicly available, and a comprehensive set of these data—paired with expert analysis and guidance—does not exist in one place. The Testing Insights Initiative aims to fill this void.

Through dynamic, continuously updated data visualizations, the Testing Insights Initiative offers a new, intuitive way to view and understand key data and insights to inform public policies and responses to the pandemic. The new initiative will be housed on the existing Johns Hopkins Coronavirus Resource Center webpage, an established resource for the public, policymakers, and the media about COVID-19 that has been viewed more than 400 million times in less than two months and linked to by more than 8,000 other websites.

Visualizations will chart trends in the data and measure testing capacity and results, as well as the efficacy of policy responses in real time. The new initiative will include COVID-19 testing trends for each US state, a tracker following the development and approval of serology tests, and frequently asked questions about COVID-19 testing. Following the initiative's launch, the site will quickly expand to include analyses of countries around the world. The site will be continuously updated as new data become available.

"Through the COVID-19 Testing Insights Initiative, Johns Hopkins will provide the comprehensive view of the testing landscape needed to guide effective policy decisions and shape our collective path to recovery," said Ron Daniels, president of Johns Hopkins University.

"The development and implementation of viral and serological tests are only half the battle," said Jennifer Nuzzo, senior scholar at the Johns Hopkins Center for Health Security and an associate professor at the Johns Hopkins Bloomberg School of Public Health. "The data from these tests must play a large role in decisions about our future, yet a complete set of these data are not currently publicly available. This initiative will fill that gap and provide essential insights to the public health community."

Related Links:
Johns Hopkins University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Desk Aneroid Sphyg
Diagnostix 750D+
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
image: Principles of SMEAR-ULM. (Lai, Y., Argüello, A.N., Liu, M. et al., Nature Sensors (2026). DOI: 10.1038/s44460-026-00078-4)

“Intelligent Tattoo” Method Detects Early Melanoma Signals

Melanoma is a lethal skin cancer in which earlier detection drives better outcomes. Current evaluation relies on visual inspection followed by biopsy, which can miss nascent lesions and lead to unnecessary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.